MTE29.01 Advances in Malignant Pleural Mesothelioma

Paolo Boffetta; Matteo Malvezzi; Enrico Pira; Carlo La Vecchia

doi:10.1016/j.jtho.2016.11.162

Letter2017

Immune checkpoint inhibitors in malignant pleural mesothelioma

Giovanni Luca Ceresoli, Alberto Mantovani

Chapter in a book2019

Microenvironment and Immunology of the Human Pleural Malignant Mesothelioma

Elisabeth Digifico, Cristina Belgiovine, Alberto Mantovani, Paola Allavena

Article2017

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Steven Kao, Yuen Yee Cheng, Marissa Williams, Michaela B. Kirschner, Jason Madore, Trina Lum, K. Sarun, Anthony Linton, Brian C. McCaughan, Sonja Klebe, Nico van Zandwijk, Richard A Scolyer, Michael Boyer, Wendy A. Cooper, Glen Reid

Article2018

Management and Survival of Pleural Mesothelioma: A Record Linkage Study

Greta Carioli, Martina Bonifazi, Marta Rossi, Alberto Zambelli, Matteo Franchi, Carlo Zocchetti, Stefano Gasparini, Giovanni Corrao, Carlo La Vecchia, Eva Negri

Article2003

Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends

Fabio Montanaro, Freddie Ian Bray, Valerio Gennaro, Enzo Merler, Jerzy E. Tyczynski, Donald Maxwell Parkin

MTE29.01 Advances in Malignant Pleural Mesothelioma

Discussion(0)

Related publications

Immune checkpoint inhibitors in malignant pleural mesothelioma

Microenvironment and Immunology of the Human Pleural Malignant Mesothelioma

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Management and Survival of Pleural Mesothelioma: A Record Linkage Study

Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends